Back to rankings
DLA Piper Giziński Kycia sp.k.

DLA Piper Giziński Kycia sp.k.

Plus d'information

Poland

2

Healthcare and life sciences

Hailed by clients as a ‘premier team in the Polish market’, DLA Piper Giziński Kycia sp.k. often assists with public procurement mandates and the full spectrum of issues relating to the pricing and advertising of medicinal products. The ’outstanding’ Andrzej Balicki leads the team, and is known for his longstanding experience in both domestic and EU regulations governing pharmaceutical, diet supplement, and medical device products. Balicki is particularly adept at handling reimbursement negotiations and public procurement matters. ‘Extraordinary product lawyer’ Jolanta Dąbrowicz is a key member of the team who often assists distributors and manufacters with administrative disputes before the Main Pharmaceutical Inspectorate and the National Health Fund.
L'éditorial du Legal 500

Distinctions

La satisfaction du client: Facturation et efficacité

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • ‘A team with a remarkable track record in the life sciences market. I particularly appreciate their proactive approach and in-depth knowledge of industry trends.’

  • ‘Andrzej Balicki is an outstanding lawyer in the life sciences sector with a great deal of expertise. I particularly value his deep understanding of the sector which enables him to offer strategic advice that combines legal and business aspects.’

  • ‘DLA Piper has an outstanding team in Poland, with one of the best healthcare and life sciences lawyers on the market - Andrzej Balicki and Jolanta Dąbrowicz. They are very smart, proactive and successfully advise their clients. Portfolio of clients is also impressive.’

  • ‘Andrzej Balicki is one of the best lawyers in this area with an amazing track record. He is definitely a go to person. Jolanta Dąbrowicz - she is a lawyer with a plenty of experience. Definitely one of the best lawyers on her level - deserves the recognition she received so far but will definitely go up.’

  • ‘Outstanding expertise in pharma law. Attorneys understand the pharmaceutical business very well, which is a unique attribute among law firms.’

  • ‘In my opinion, this is a premier team in the Polish market, setting a high standard for competitors. They are a highly skilled group, excelling in all key areas of industry-specific advisory services. Their grasp of both current and forthcoming life sciences regulations is exceptional.’

Clients clés

  • CMR Surgical
  • ExploRNA Therapeutics
  • Théa Polska sp. z o.o.
  • Smith & Nephew
  • Brass Research and Development
  • Mayoly
  • Philips Polska sp. z o.o.
  • Gemini Polska sp. z o.o.
  • AbbVie
  • ResMed
  • Zakłady Farmaceutyczne Polpharma
  • Transpharmation

Points forts

Advised CMR Surgical on its contracting with public hospitals.
Advised a global pharmaceutical company on its collaboration with national health consultants and provincial health consultants in Poland.
Acting for ExploRNA Therapeutics in negotiations with potential partners.
Responsable de la pratique

Andrzej Balicki

Autres avocats clés

Jolanta Dąbrowicz; Michał Orzechowski